Skip to main content
. 2014 Jan 9;12(4):443–451. doi: 10.1586/erv.13.19

Figure 1. Cumulative number of novel preventative tuberculosis vaccines in Phase I, IIa and IIb clinical development each year since 2002.

Figure 1.

Vaccines no longer in clinical development are included in the data until their year of discontinuation. Vaccines solely being developed for therapeutic indications are excluded.